Evidence map›Paper›PMID 34421933›Full record

ArticleFrontiers in immunology2021

Editorial: Focusing on T-Cells for Novel Treatments of Systemic Lupus Erythematosus.

Kunihiro Ichinose, Christian Michael Hedrich, Vaishali R Moulton, Masayuki Mizui

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kunihiro IchinoseDepartment of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Christian Michael HedrichDepartment of Women's and Children's Health, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom.
Vaishali R MoultonDivision of Rheumatology and Clinical Immunology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, United States.
Masayuki MizuiDepartment of Nephrology, Graduate School of Medicine, Osaka University, Suita, Japan.

Funding

Role of splicing factor SRSF1 in T cell function and autoimmunityR01AR068974 · NIAMS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI ADAMOPOULOS, IANNIS ELIAS · 2016 to 2020
$2.2M
NIAMS NIH HHS R01 AR068974
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cell- and Tissue-Based TherapyHumansLupus Erythematosus, SystemicT-Lymphocytesimmunometabolisminnate lymphocyteslupus T-cellspost-transcriptional regulationTh17/Treg balance

Identifiers

PMID34421933
PMCPMC8377347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.